Drug details

Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension)

type of Antiglaucoma, Combos

Simbrinza (brinzolamide/brimonidine tartrate) 1%/0.2% is a combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist used to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

This drug may have the following side effects:

• itching,
• rash,
• fainting,
• severe dizziness, and
• trouble breathing
• vision changes,
• slow or irregular heartbeat,
• fast or pounding heartbeat,
• swelling of the face, tongue, or throat,
• eye or eyelid pain, burning, or swelling,
• extreme sensitivity to light,

The following drugs are related to Simbrinza, either as a replacement or used together:

• Diamox Sequels (acetazolamide xr)
• Iopidine Eye (apraclonidine)
• Lumigan (bimatoprost ophthalmic solution 0.03% for glaucoma)
• Trusopt (dorzolamide hydrochloride ophthalmic solution)
• Xalatan (latanoprost ophthalmic)
• Osmitrol Injection in Aviva (mannitol injection in aviva plastic container)
• Osmitrol Injection in Viaflex (mannitol injection in viaflex plastic container)
• Optipranolol (metipranolol ophthalmic solution)
• Rocklatan (netarsudil and latanoprost ophthalmic solution)
• Salagen (pilocarpine hydrochloride)
• Rescula (unoprostone isopropyl)